FDA advisers recommend fall flu shot changes to include the new subclade K H3N2 variant for the 2026-27 season, improving vaccine relevance.
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
In the warning letter, the FDA alleged that Novo inadequately responded to observations made after an inspection carried out across January and February of 2025.
The FDA has faced an extraordinary convergence of political, scientific, legal, and operational pressures over the last year.
A former drug addict said that ketamine should be a Class A drug as data revealed the number of people being treated in ...
Health and Me on MSN
FDA recommends new 'Subclade K' flu strain for fall vaccines
An FDA advisory panel recommended adding the H3N2 subclade K strain to fall flu vaccines. Experts say lower immunity and ...
The FDA issued its most serious risk classification—Class I—on March 11, according to the official enforcement notices.
Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results